These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33627317)

  • 21. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism.
    Kantauskaite M; Bolten K; Boschheidgen M; Schmidt C; Kolb T; Eckardt KU; Pasch A; Schimmöller L; Rump LC; Voelkl J; Stegbauer J
    Front Cardiovasc Med; 2022; 9():771096. PubMed ID: 35141300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis.
    Geroldinger-Simic M; Sohail A; Razazian M; Krennmayr B; Pernsteiner V; Putz T; Lackner HK; Pasch A; Sepp N; Alesutan I; Voelkl J
    Front Immunol; 2024; 15():1425885. PubMed ID: 39399492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study.
    Lorenz G; Mayer CC; Bachmann Q; Stryeck S; Braunisch MC; Haller B; Carbajo-Lozoya J; Schmidt A; Witthauer S; Abuzahu J; Kemmner S; Angermann S; Koneru N; Wassertheurer S; Bieber R; Heemann U; Madl T; Pasch A; Schmaderer C
    Nephrol Dial Transplant; 2018 Nov; 33(11):2043-2051. PubMed ID: 29860419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial.
    Ter Meulen KJ; Dekker MJE; Pasch A; Broers NJH; van der Sande FM; van der Net JB; Konings CJAM; Gsponer IM; Bachtler MDN; Gauly A; Canaud B; Kooman JP
    PLoS One; 2019; 14(12):e0225824. PubMed ID: 31805104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcification Propensity of Serum is Independent of Excretory Renal Function.
    Bielesz B; Reiter T; Marculescu R; Gleiss A; Bojic M; Kieweg H; Cejka D
    Sci Rep; 2017 Dec; 7(1):17941. PubMed ID: 29263429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients.
    Zawada AM; Wolf M; Rincon Bello A; Ramos-Sanchez R; Hurtado Munoz S; Ribera Tello L; Mora-Macia J; Fernández-Robres MA; Soler-Garcia J; Aguilera Jover J; Moreso F; Stuard S; Stauss-Grabo M; Winter A; Canaud B
    BMC Nephrol; 2023 Feb; 24(1):35. PubMed ID: 36792998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
    Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Bojic M; Bielesz B; Cejka D; Schernthaner GH; Höbaus C
    Thromb Haemost; 2022 Jun; 122(6):1040-1046. PubMed ID: 34719013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.
    Bristow SM; Gamble GD; Pasch A; O'Neill WC; Stewart A; Horne AM; Reid IR
    Osteoporos Int; 2016 Mar; 27(3):1209-1216. PubMed ID: 26493812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid and sustained improvement of calcification propensity score (serum T
    Smerud KT; Åsberg A; Kile H; Pasch A; Dahle DO; Bollerslev J; Godang K; Hartmann A
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28972673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis.
    Tadokoro T; Kato A; Ohmori H; Matsumoto T; Kuro-O M; Kobayashi T; Ohdan H
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930020
    [No Abstract]   [Full Text] [Related]  

  • 37. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score.
    Ussif A; Pihlstrøm H; Pasch A; Holdaas H; Hartmann A; Smerud K; Åsberg A
    BMC Nephrol; 2018 Aug; 19(1):212. PubMed ID: 30134956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential associations of fetuin-A and calcification propensity with cardiovascular events and subsequent mortality in patients undergoing hemodialysis.
    Mori K; Shoji T; Nakatani S; Uedono H; Ochi A; Yoshida H; Imanishi Y; Morioka T; Tsujimoto Y; Kuro-O M; Emoto M
    Clin Kidney J; 2024 Mar; 17(3):sfae042. PubMed ID: 38487079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.